Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)

Ezetimibe inhibits intestinal cholesterol absorption and lowers low-density lipoprotein cholesterol. Uncontrolled studies have suggested that it reduces liver fat as estimated by ultrasound in nonalcoholic steatohepatitis (NASH). Therefore, we aimed to examine the efficacy of ezetimibe versus placeb...

詳細記述

保存先:
書誌詳細
出版年:Hepatology
主要な著者: Loomba, Rohit, Sirlin, Claude B, Ang, Brandon, Bettencourt, Ricki, Jain, Rashmi, Salotti, Joanie, Soaft, Linda, Hooker, Jonathan, Kono, Yuko, Bhatt, Archana, Hernandez, Laura, Nguyen, Phirum, Noureddin, Mazen, Haufe, William, Hooker, Catherine, Yin, Meng, Ehman, Richard, Lin, Grace Y, Valasek, Mark A, Brenner, David A, Richards, Lisa
フォーマット: Artigo
言語:Inglês
出版事項: BlackWell Publishing Ltd 2015
主題:
Steatohepatitis/Metabolic Liver Disease
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4407930/
https://ncbi.nlm.nih.gov/pubmed/25482832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27647
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料